Immunoglobulin Fractions Isolated from Patients with Antiphospholipid Antibodies Prevent the Inactivation of Factor Va by Activated Protein C on Human Endothelial Cells

Summary

We studied the effect of purified immunoglobulins (Ig) from 21 patients with antiphospholipid antibodies (aPL) on factor Va degradation by activated protein C (aPC) on cultured human umbilical vein endothelial cells (HUVEC). Sera from patients were tested on an ELISA aPL assay to determine the isotype with aPL activity. HUVEC were incubated with purified IgG or IgM fraction from controls or patients. Activated PC and factor Va were then added and factor Va degradation was measured after several reaction times. 13 of 14 IgM and 8 of 10 IgG from patients showed an inhibitory effect on factor Va degradation by aPC when compared with control Ig. We also observed the same inhibitory effect with patients’ Ig on studying the degradation of factor Va by aPC in a purified system containing aPC, protein S and phospholipids. These results suggest that aPL antibodies disturb the anticoagulant activity of aPC, which may contribute to the thrombotic tendency of these patients.

• References

• 1 Mueh JR, Herbst KD, Rapaport SI. Thrombosis in patients with the lupus anticoagulant. Ann Intern Med 1980; 92: 156-159
• 2 Elias M, Eldor A. Thromboembolism in patients with the “lupus” type circulating anticoagulant. Arch Intern Med 1984; 144: 510-515
• 3 Bowie JW, Thompson JH, Pascuzzi CA, Owen CA. Thrombosis in SLE despite circulating anticoagulants. J Lab Clin Med 1963; 62: 416-430
• 4 Lechner K, Pabinger-Fasching I. Lupus anticoagulant and thrombosis. Haemostasis 1985; 15: 254-262
• 5 Firkin BG, Howard MA, Radford N. Possible relationship between lupus inhibitor and recurrent abortion in young women. Lancet 1980; 2: 366
• 6 Branch WD, Scott JR, Kochenour NK, Hershgold E. Obstetric complications associated with lupus anticoagulant. N Engl J Med 1985; 313: 1322-1326
• 7 Angles-Cano E, Sultan Y, Clauvel JP. Predisposing factors to thrombosis in systemic lupus erythematosus. J Lab Clin Med 1979; 94: 312-323
• 8 Carreras LO, Machin SJ, Deman R, Defreyn G, Vermylen J et al. Arterial thrombosis, intrauterine death and lupus anticoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet 1981; i: 244-246
• 9 Comp PC, De Bault LE, Esmon NL, Esmon CT. Human thrombomodulin is inhibited by IgG from two patients with non specific anticoagulants. Blood 1983; 62: 299
• 10 Cariou R, Tobelem G, Belluci S, Soria J, Soria C. et al Effect of lupus anticoagulant and antithrombogenic properties on endothelial cells-inhibition of thrombomodulin-dependent protein C activation. Thromb Haemostas 1988; 60: 54-58
• 11 Freyssinet JM, Cazenave JP. Lupus-like anticoagulants, modulation of the protein C pathway and thrombosis. Thromb Haemostas 1987; 58: 679-681
• 12 Tsakiris DA, Settas L, Makris PE, Marbet GA. Lupus anticoagulant-antiphospholipid antibodies and thrombophilia. Relation to protein C-protein S-Thrombomodulin. J Rheumatol 1990; 17: 785-789
• 13 Kitchen S, Malia RG, Greaves M, Preston FE. Inhibition of protein S cofactor activity by antiphospholipid antibodies. Br J Haematol 1989; 71 Suppl. 1 3
• 14 Marciniak E, Romond EH. Impaired catalytic function of activated protein C: a new in vitro manifestation of lupus anticoagulant. Blood 1989; 74: 2426-2432
• 15 Malia RG, Kitchen S, Greaves M, Preston FE. Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies. Br J Haematol 1990; 76: 101-107
• 16 Esmon CT. The regulation of natural anticoagulant pathways. Science 1987; 235: 1348-1352
• 17 Caen J, Larrieu MJ, Samama M. L’Hémostase. Méthodes d’exploration et diagnostic practique. 2nd edn. L’Expansion Scientifique Française, Paris: 1975
• 18 Exner T, Rickard KA, Kronenberg H. A sensitive test demonstrating lupus anticoagulant and its behavioural patterns. Br J Haematol 1978; 40: 143-151
• 19 Ewing NP, Kasper CK. In vitro detection of mild inhibitors to factor VIII in hemophilia. Am J Clin Pathol 1989; 77: 479
• 20 Gharavi AE, Harris EN, Asherson RA, Hughes GRV. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis 1987; 46: 1-6
• 21 Esmon NL, Owen WG, Esmon CT. Isolation of a membrane bound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem 1982; 257: 859-864
• 22 Sala N, Owen WG, Collen D. A functional assay of protein C in human plasma. Blood 1984; 63: 671-675
• 23 Gimbrone MA, Shefton EJ, Cruise SA. Isolation and primary culture of endothelial cells from human umbilical vessels. Tissue Culture Assoc 1979; 4: 813-817
• 24 Dejana E, Balconi G, De Castellarnau C, Barbieri B, Vergara M, De Gaetano G. Prostacyclin production by human endothelial and bovine smooth muscle cells in culture. Effect of repeated stimulation with arachidonic acid, thrombin and ionophore A 23187. Biochim Biophys Acta 1983; 750: 261-267
• 25 Broekmans AW, Conard J. Hereditary protein C deficiency. In: Protein C and Related Proteins. Bertina RM. (ed) Churchill Livingstone, London: 1988. pp 160-181
• 26 Briët E, Broekmans AW, Engesser L. Hereditary protein S deficiency. In: Protein C and Related Proteins. Bertina RM. (ed) Churchill Livingstone: London: 1988. pp 203-212
• 27 Fair DS, Marlar RA, Levin EG. Human endothelial cells synthesize Protein S. Blood 1986; 67 (4) 1168-71
• 28 Harris EN, Chan JKH, Asherson RA, Aber VR, Gharavi AE, Hughes GRV. Thrombosis, recurrent fetal loss, and thrombocytopenia: predictive value of IgG anticardiolipin antibodies. Arch Intern Med 1986; 146: 2153-2159